Funders

The PEXIVAS study  is funded by:

National Institutes of Health Research (UK): Number, HTA 08/56/04

National Institute for Health Research

Food and Drug Administration/National Institutes of Health (USA): FDA R01 FD003516

US Food and Drug Administration

National Institutes of Health (USA) - National Institute of Arthritis and Musculoskeletal and Skin Diseases: U54 AR0573319

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Health and Medical Research Council (Australia) 626939

Canadian Institutes of Health Research 211079